328 related articles for article (PubMed ID: 28277310)
1. Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis.
Wils RS; Gotfredsen DR; Hjorthøj C; Austin SF; Albert N; Secher RG; Thorup AA; Mors O; Nordentoft M
Schizophr Res; 2017 Apr; 182():42-48. PubMed ID: 28277310
[TBL] [Abstract][Full Text] [Related]
2. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
[TBL] [Abstract][Full Text] [Related]
3. Stability and development of psychotic symptoms and the use of antipsychotic medication - long-term follow-up.
Gotfredsen DR; Wils RS; Hjorthøj C; Austin SF; Albert N; Secher RG; Thorup AAE; Mors O; Nordentoft M
Psychol Med; 2017 Sep; 47(12):2118-2129. PubMed ID: 28382874
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
[TBL] [Abstract][Full Text] [Related]
5. To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.
Begemann MJH; Thompson IA; Veling W; Gangadin SS; Geraets CNW; van 't Hag E; Müller-Kuperus SJ; Oomen PP; Voppel AE; van der Gaag M; Kikkert MJ; Van Os J; Smit HFE; Knegtering RH; Wiersma S; Stouten LH; Gijsman HJ; Wunderink L; Staring ABP; Veerman SRT; Mahabir AGS; Kurkamp J; Pijnenborg GHM; Veen ND; Marcelis M; Grootens KP; Faber G; van Beveren NJ; Been A; van den Brink T; Bak M; van Amelsvoort TAMJ; Ruissen A; Blanke C; Groen K; de Haan L; Sommer IEC
Trials; 2020 Feb; 21(1):147. PubMed ID: 32033579
[TBL] [Abstract][Full Text] [Related]
6. Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study.
Caseiro O; Pérez-Iglesias R; Mata I; Martínez-Garcia O; Pelayo-Terán JM; Tabares-Seisdedos R; Ortiz-García de la Foz V; Vázquez-Barquero JL; Crespo-Facorro B
J Psychiatr Res; 2012 Aug; 46(8):1099-105. PubMed ID: 22721546
[TBL] [Abstract][Full Text] [Related]
7. Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis.
Bowtell M; Eaton S; Thien K; Bardell-Williams M; Downey L; Ratheesh A; Killackey E; McGorry P; O'Donoghue B
Schizophr Res; 2018 May; 195():231-236. PubMed ID: 29066258
[TBL] [Abstract][Full Text] [Related]
8. Predictors of favourable outcome in young people with a first episode psychosis without antipsychotic medication.
Conus P; Cotton SM; Francey SM; O'Donoghue B; Schimmelmann BG; McGorry PD; Lambert M
Schizophr Res; 2017 Jul; 185():130-136. PubMed ID: 28065484
[TBL] [Abstract][Full Text] [Related]
9. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review.
Zipursky RB; Menezes NM; Streiner DL
Schizophr Res; 2014 Feb; 152(2-3):408-14. PubMed ID: 23972821
[TBL] [Abstract][Full Text] [Related]
10. Predicting 1-year risk for relapse in patients who have discontinued or continued quetiapine after remission from first-episode psychosis.
Hui CL; Wong GH; Tang JY; Chang WC; Chan SK; Lee EH; Lam MM; Chiu CP; Law CW; Chung DW; Tso S; Pang EP; Chan KT; Wong YC; Mo FY; Chan KP; Hung SF; Honer WG; Chen EY
Schizophr Res; 2013 Oct; 150(1):297-302. PubMed ID: 23993865
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
[TBL] [Abstract][Full Text] [Related]
12. Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial.
Clausen L; Hjorthøj CR; Thorup A; Jeppesen P; Petersen L; Bertelsen M; Nordentoft M
Psychol Med; 2014 Jan; 44(1):117-26. PubMed ID: 23590927
[TBL] [Abstract][Full Text] [Related]
13. Trajectories after first-episode psychosis: Complement to ambiguous outcomes of long-term antipsychotic treatment by exploring a few hidden cases.
Liu CC; Lin YT; Liu CM; Hsieh MH; Chien YL; Hwang TJ; Hwu HG
Early Interv Psychiatry; 2019 Aug; 13(4):895-901. PubMed ID: 29927087
[TBL] [Abstract][Full Text] [Related]
14. Early recovery and employment outcome 13 years after first episode psychosis.
Strålin P; Skott M; Cullberg J
Psychiatry Res; 2019 Jan; 271():374-380. PubMed ID: 30529874
[TBL] [Abstract][Full Text] [Related]
15. Adolescent vs. adult onset of a first episode psychosis: Impact on remission of positive and negative symptoms.
Veru F; Jordan G; Joober R; Malla A; Iyer S
Schizophr Res; 2016 Jul; 174(1-3):183-188. PubMed ID: 27102425
[TBL] [Abstract][Full Text] [Related]
16. Duration of untreated psychosis and acute remission of negative symptoms in a South American first-episode psychosis cohort.
González-Valderrama A; Castañeda CP; Mena C; Undurraga J; Mondaca P; Yañez M; Bedregal P; Nachar R
Early Interv Psychiatry; 2017 Feb; 11(1):77-82. PubMed ID: 26256570
[TBL] [Abstract][Full Text] [Related]
17. [Minor neurological and physical anomalies in patients with first-episode psychosis].
Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effectiveness and tolerability of aripiprazole as initial choice of treatment in first episode psychosis in an early intervention service: A one-year outcome study.
Malla A; Mustafa S; Rho A; Abadi S; Lepage M; Joober R
Schizophr Res; 2016 Jul; 174(1-3):120-125. PubMed ID: 27157800
[TBL] [Abstract][Full Text] [Related]
19. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
20. Outcome study of first-episode psychosis. I: Relapse rates after 1 year.
Rabiner CJ; Wegner JT; Kane JM
Am J Psychiatry; 1986 Sep; 143(9):1155-8. PubMed ID: 2875663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
